
Rabprazo20 mg
Pacific Pharmaceuticals Ltd.
Rabeprazole Sodium is a proton pump inhibitor used for the following indications: Established / FDA-approved uses Healing of erosive or ulcerative gastro-esophageal reflux disease (GERD) Maintenance…
Rabeprazole Sodium is a proton pump inhibitor used for the following indications:
The decision to use Rabeprazole Sodium for any indication should be made by a qualified physician after clinical evaluation.
Dosing of Rabeprazole Sodium depends on the indication being treated. Tablets should be swallowed whole and must not be split, crushed, or chewed.
| Indication | Adult Dose | Duration |
|---|---|---|
| Healing of erosive/ulcerative GERD | 20 mg once daily | 4–8 weeks; may extend an additional 8 weeks if not healed |
| Maintenance of healed GERD | 20 mg once daily | Long-term, as directed by physician |
| Symptomatic (non-erosive) GERD | 20 mg once daily | Up to 4 weeks |
| Active duodenal ulcer | 20 mg once daily after the morning meal | Up to 4 weeks |
| Active benign gastric ulcer | 20 mg once daily | 4–8 weeks, per physician's assessment |
| H. pylori eradication (triple therapy) | 20 mg twice daily, with amoxicillin 1000 mg twice daily and clarithromycin 500 mg twice daily | 7 days |
| Zollinger-Ellison syndrome / hypersecretory conditions | Initial 60 mg once daily; titrated up to 100–120 mg/day (in divided doses if >100 mg/day) based on response | Individualized, may be long-term |
Pediatric dosing (GERD, ages 1–11 years, when clinically indicated): weight <15 kg — 5 mg once daily; weight ≥15 kg — 10 mg once daily, for up to 12 weeks. Adolescents 12 years and older may receive the adult symptomatic GERD dose of 20 mg once daily for up to 8 weeks. Pediatric dosing of Rabeprazole Sodium must only be initiated and supervised by a physician. See Use in Special Populations and Pediatric Uses for further detail.
No routine dose adjustment of Rabeprazole Sodium is required for mild-to-moderate renal impairment or mild hepatic impairment; caution and physician guidance are advised in significant hepatic impairment (see Use in Special Populations).
Common side effects of Rabeprazole Sodium (generally mild and transient) include:
In combination therapy for H. pylori eradication, diarrhea and taste disturbance are reported more frequently.
Less common but serious effects associated with Rabeprazole Sodium and other PPIs — including bone fracture with long-term high-dose use, hypomagnesemia, vitamin B12 deficiency, Clostridioides difficile-associated diarrhea, acute interstitial nephritis, and severe skin reactions — are discussed in Precautions and Warnings. Patients should seek prompt medical attention for severe or persistent symptoms, signs of allergic reaction, or unexplained diarrhea while taking Rabeprazole Sodium.
Rabeprazole Sodium is contraindicated in:
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.